An enzyme-linked immunosorbent assay to study bevacizumab pharmacokinetics.

Introduction:Bevacizumab is an antivascular endothelial growth factor humanized monoclonal antibody used to inhibit angiogenesis in cancer. It displays an important interindividual pharmacokinetic variability, which could explain part of the interindividual differences in clinical response. Therefor